Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Placebo Controlled Study for Characterisation of Immunological Effects and Safety of Active O2

This study has been completed.
Sponsor:
Collaborators:
SocraTec R&D GmbH
SocraMetrics GmbH
Institut für Medizinische Diagnostik MVZ GbR
Sport- und Rehazentrum GbR
Information provided by (Responsible Party):
Adelholzener Alpenquellen GmbH
ClinicalTrials.gov Identifier:
NCT01333930
First received: April 8, 2011
Last updated: May 11, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)